MiR-133b targets Sox9 to control pathogenesis and metastasis of breast cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR-133b targets Sox9 to control pathogenesis and metastasis of breast cancer
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 9, Issue 7, Pages -
Publisher
Springer Nature
Online
2018-07-03
DOI
10.1038/s41419-018-0715-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SH3BP1-induced Rac-Wave2 pathway activation regulates cervical cancer cell migration, invasion, and chemoresistance to cisplatin
- (2017) Jingjing Wang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients
- (2016) András Lánczky et al. BREAST CANCER RESEARCH AND TREATMENT
- microRNA-1/133a and microRNA-206/133b clusters: Dysregulation and functional roles in human cancers
- (2015) Nijiro Nohata et al. Oncotarget
- SOX9 regulates ERBB signalling in pancreatic cancer development
- (2014) Adrien Grimont et al. GUT
- Suppression of miRNA-708 by Polycomb Group Promotes Metastases by Calcium-Induced Cell Migration
- (2013) Seongho Ryu et al. CANCER CELL
- MicroRNA-133 Controls Brown Adipose Determination in Skeletal Muscle Satellite Cells by Targeting Prdm16
- (2013) Hang Yin et al. Cell Metabolism
- miR-133b acts as a tumor suppressor and negatively regulates FGFR1 in gastric cancer
- (2013) Dacheng Wen et al. TUMOR BIOLOGY
- Slug and Sox9 Cooperatively Determine the Mammary Stem Cell State
- (2012) Wenjun Guo et al. CELL
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- MyomiR-133 regulates brown fat differentiation through Prdm16
- (2012) Mirko Trajkovski et al. NATURE CELL BIOLOGY
- A Long Noncoding RNA Controls Muscle Differentiation by Functioning as a Competing Endogenous RNA
- (2011) Marcella Cesana et al. CELL
- Tumor Metastasis: Molecular Insights and Evolving Paradigms
- (2011) Scott Valastyan et al. CELL
- MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways
- (2011) W Qin et al. ONCOGENE
- A Perspective on Cancer Cell Metastasis
- (2011) C. L. Chaffer et al. SCIENCE
- miR-133b regulates the MET proto-oncogene and inhibits the growth of colorectal cancer cells in vitro and in vivo
- (2010) Gui Hu et al. CANCER BIOLOGY & THERAPY
- A Subpopulation of CD26+ Cancer Stem Cells with Metastatic Capacity in Human Colorectal Cancer
- (2010) Roberta Pang et al. Cell Stem Cell
- miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma
- (2010) Masayuki Kano et al. INTERNATIONAL JOURNAL OF CANCER
- Morphine Regulates Dopaminergic Neuron Differentiation via miR-133b
- (2010) F. M. Sanchez-Simon et al. MOLECULAR PHARMACOLOGY
- MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer
- (2009) Melissa Crawford et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature
- (2009) Emmanuelle Charafe-Jauffret et al. CANCER RESEARCH
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- MicroRNAs and Cancer: Short RNAs Go a Long Way
- (2009) Andrea Ventura et al. CELL
- RETRACTED: A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis
- (2009) Scott Valastyan et al. CELL
- Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells
- (2009) Yohei Shimono et al. CELL
- MicroRNAs 1, 133, and 206: Critical factors of skeletal and cardiac muscle development, function, and disease
- (2009) W.H. Davin Townley-Tilson et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Feedback Remodeling of Cardiac Potassium Current Expression
- (2008) Ling Xiao et al. CIRCULATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started